CDKN2A and histiocytic sarcoma: Our data also reveal the predicted inhibition of the regulators CDKN2A/B, RB1, and PTEN, which have been shown to be significantly dysregulated, often with copy loss or deletion, in numerous canine HS cases [4,15].